Cryoablation

CHICAGO — In the OPTION trial, left atrial appendage closure resulted in similar thromboembolic protection but superior bleeding outcomes compared with oral anticoagulation among patients who underwent ablation for atrial fibrillation.

In patients with atrial fibrillation and heart failure with reduced ejection fraction, cryoballoon ablation was noninferior to radiofrequency ablation, according to the results of the CRABL-HF trial.

Pulmonary vein isolation was associated with genuine improvements in patients with atrial fibrillation at 6 months that cannot be attributed to a placebo effect, researchers reported at the European Society of Cardiology Congress.

IceCure Medical has received marketing authorization from the FDA for its next-generation single probe cryoablation system, the company announced in a press release.

Yolanda Bryce, MD, still remembers her patient’s shock.

For millions of patients who live with atrial fibrillation, early detection and treatment are essential because research shows that early, intensive management of AF reduces stroke, hospitalization and heart failure.

Ostial and antral pulmonary vein isolation, ablation plus posterior wall isolation and cryoablation all demonstrated comparable success in treating persistent atrial fibrillation, according to a post hoc analysis of the DECAAF II trial.

Boston Scientific announced it received FDA approval for its cryoablation system indicated for the treatment of patients with paroxysmal atrial fibrillation.

Pulsed field ablation pulmonary vein isolation for atrial fibrillation may confer less damage to cardiac nerves and ganglia vs. cryoballoon ablation, researchers reported.

Early catheter-based cryoballoon ablation vs. first-line antiarrhythmic drug therapy in patients with paroxysmal atrial fibrillation.